NUVILEX, INC.

Q: Jul 31 2026

FY: Apr 30 2026

Q: Jan 31 2026

Q: Oct 31 2025

Q: Oct 31 2025

Q: Jul 31 2025

FY: Apr 30 2025

FY: Apr 30 2025

Q: Jan 31 2025

Q: Oct 31 2024

Q: Jul 31 2024

Q: Jul 31 2024

FY: Apr 30 2024

FY: Apr 30 2024

Q: Jan 31 2024

Q: Oct 31 2023

Q: Jul 31 2023

Q: Jul 31 2023

FY: Apr 30 2023

Q: Jan 31 2023

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Financial Statements and Exhibits

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Changes in Registrant's Certifying Accountant

1.01,2.01,8.01,9.01

5.07

5.02

1.01,8.01,9.01

4.01

5.03,5.07,9.01

4.01,9.01

5.03,8.01,9.01

1.01,3.02,5.03,5.07,8.01,9.01

8.01,9.01

5.07

5.02,5.03,9.01

Notice of Effectiveness

Registration statement under Securities Act of 1933

Rule 506(b) provides a "safer harbor" for a private offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

06b

Prospectus Supplement for Primary Offering

No description available

Prospectus Supplement for Primary Offering

Certification of approval for listing and registration on a national securities exchange

Prospectus Supplement for Primary Offering

Registration of Securities on Exchange

Notice of Effectiveness

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

No description available

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

SCHECHTER JONATHAN

WEINSTEIN ROBERT

WALKER WAYNE REMELL

Abecassis Michael M

SCHECHTER JONATHAN

WEINSTEIN ROBERT

WALKER WAYNE REMELL

Abecassis Michael M

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc.

INTRACOASTAL CAPITAL, LLC

SCHECHTER JONATHAN

Silverman Joshua

WEINSTEIN ROBERT

Abecassis Michael M

SCHECHTER JONATHAN

Silverman Joshua

WALKER WAYNE REMELL

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC